Summary
In malignant lymphomas generally, radiotherapy is the treatment of choice. Chemotherapy cannot be very effective in lymphomas of the CNS because most of the cytostatic drugs in question are not able to pass the blood-brain barrier. But in cases in which malignant lymphomas are disseminated throughout the body including the CNS, cytostatic chemotherapy is the only means of prolonging the life of the patient. In such cases one has to distinguish between Hodgkin’s disease and non-Hodgkin lymphomas. Alkylating agents, metaphase inhibitors and antibiotics are used in the treatment of malignant lymphomas. The best results are achiev. d. with combination schedules. In Hodgkin lymphomas the so-called MOPP-schedule is the most effective. In non-Hodgkin lymphomas the same drugs are usually given without procarbacine. After having achiev. d. a remission, maintenance therapy is very important. Vinblastine and Chlorambuzil are able to prolonge the remission. When resistance to these drugs occurs Bleomycin, Adriamycin, CCNU and Peptichemio are effective agents. The results as well as the side effects of such regimens are described.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
de Lena, M., Monfardini, S., Bonadonna, G.: Intensive combination chemotherapy in malignant lymphomas. In A. Stacher (ed.): Leukämien und maligne Lymphome. München, Berlin, Wien: Urban & Schwarzenberg 1973.
de Vita, V.T., Carbone, P.T.: Chemotherapeutic implications of staging in Hodgkin’s disease. Cancer Res. 31, 1838 (1971).
de Vita, V.T., Serpick, A.A., Carbone, P.T.: Combination chemotherapy in advanced Hodgkin’s disease. Am. Int. Med. 73, 881 (1970).
Fischer, M., Mitrou, P.S., Schubert, J.C.F., Martin, H., Hübner, K.: Zur Therapie des Morbus Hodgkin. Gegenüberstellung der Ergebnisse mit dem De Vita-Programm und verschiedenen Zweifach-Kombinationen in Abhängigkeit vom histologischen Typ. In A. Stacher (ed.): Leukämien und maligne Lymphome. München, Berlin, Wien: Urban & Schwarzenberg 1973.
Frei, E.: Recent advances in the management of lymphoma. 1st Meeting Europ. Div. Internat. Soc. Hemat., Milano, 1971. Abstract nr. 284.
Kimura, K., Sakai, Y., Konda, C., Shimoyama, M., Sakano, T., Kitahara, T., Mikuni, M.: Chemotherapy of malignant lymphoma with special references to the effects of Bleomycin and sequential therapy of Bleomycin and Vincaalkaloids. In A. Stacher (ed.): Leukämien and maligne Lymphome. München, Berlin, Wien: Urban & Schwarzenberg 1973.
Klein, H.O., Lennartz, K.J., Gross, R.: Partielle Synchronisation der Tumor-zellproliferation and zellphasenspezifisches “Timing” der Zytostatikagabe. Erste klinische Ergebnisse bei lymphoretikulären Tumoren, akuter Leukosen sowie Bronchialkarzinomen. In A. Stacher (ed.): Leukämien und maligne Lymphome. München, Berlin, Wien: Urban & Schwarzenberg 1973.
Lennert, K.: Morphology and classification of lymphomas and so-called reticuloses. Acta Neuropath. Suppl. VI, 1–16 (1975).
Lukes, R.J., Craver, L.F., Hall, T.C., Rappaport, H., Rubin, P.: Report of the nomenclature committee. Cancer Res. 26, 1311, (1966).
Stacher, A.: Grundsätze der Therapie des Morbus Hodgkin und der übrigen malignen Lymphome. In A. Stacher (ed.): Leukümien und maligne Lymphome. München, Berlin, Wien: Urban & Schwarzenberg 1973.
Trepel F.: Zellproliferation in malignen Lymphomen. In A. Stacher (ed.): Leukämien und maligne Lymphome. München, Berlin, Wien: Urban & Schwarzenberg 1973.
Medical News (Leading article): DMP-once discarted for toxicity-combats meningeal leukemia. J. amer. Med. Ass. 224, 1079 (1973).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1975 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Stacher, A. (1975). Chemotherapy of Malignant Lymphomas. In: Jellinger, K., Seitelberger, F. (eds) Malignant Lymphomas of the Nervous System. Acta Neuropathologica, vol 6. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-08456-4_39
Download citation
DOI: https://doi.org/10.1007/978-3-662-08456-4_39
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-07208-9
Online ISBN: 978-3-662-08456-4
eBook Packages: Springer Book Archive